A 61-year-old with recurrent CDI after standard vancomycin therapy is at high risk for recurrence (age 65). What adjunctive therapy may be considered...

Question

A 61-year-old with recurrent CDI after standard vancomycin therapy is at high risk for recurrence (age >65). What adjunctive therapy may be considered with standard-of-care antibiotics to reduce recurrence risk?

Accepted Answer

Bezlotoxumab infusion during CDI treatment

Answer

Prolonged metronidazole monotherapy

Answer

Routine probiotics for all

Answer

No adjuncts reduce recurrence

Answer

Oral vancomycin prophylaxis for life

us-abim MCQ (SBA): Clostridioides difficile Infection

A 61-year-old with recurrent CDI after standard vancomycin therapy is at high risk for recurrence (age >65). What adjunctive therapy may be considered with standard-of-care antibiotics to reduce recurrence risk?